| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
MFS Investment Management
|
12.475m | 5.52% | -300.000 | Mar 31 2026 |
| 2 |
Yamada Kousan
|
8.415m | 3.72% | — | Sep 30 2025 |
| 3 |
MUFG Bank, Ltd.
|
7.601m | 3.36% | — | Sep 30 2025 |
| 4 |
Nomura Asset Management Co., Ltd.
|
7.089m | 3.14% | +60.300k | Mar 31 2026 |
| 5 |
Sansho Kosan KK
|
5.046m | 2.23% | -40.000k | Sep 30 2025 |
|
1
MFS Investment Management
|
5.52%
12.475m
|
|
2
Yamada Kousan
|
3.72%
8.415m
|
|
3
MUFG Bank, Ltd.
|
3.36%
7.601m
|
|
4
Nomura Asset Management Co., Ltd.
|
3.14%
7.089m
|
|
5
Sansho Kosan KK
|
2.23%
5.046m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 17.98% of Rohto Pharmaceutical Co, with MFS Investment Management the biggest at 5.52%, followed by Yamada Kousan (3.72%) and MUFG Bank, Ltd. (3.36%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


